FREMONT, CA – (NewMediaWire) – July 06, 2023 – ABVC
BioPharma, Inc. (NASDAQ: ABVC) (“Company”), a clinical-stage biopharmaceutical company devel… Read More
FREMONT, CA – (NewMediaWire) – July 24, 2023 – ABVC BioPharma, Inc. (NASDAQ: ABVC) (“Company”), a clinical-stage biopharmaceutical company develo… Read More
Fremont, CA – (NewMediaWire) – July 27, 2023 — ABVC BioPharma, Inc. (NASDAQ: ABVC) (“Company”), a clinical-stage biopharmaceutical company developing therap… Read More
The planned partnership aims to establish an integrated platform to facilitate collaborations between researchers and industry leaders. ABVC intends to transfer common shares to Zhonghui… Read More
FREMONT, CA – (NewMediaWire) – July 31, 2023 – ABVC BioPharma, Inc. (NASDAQ: ABVC) (“Company”), a clinical-stage biopharmaceutical company developing t… Read More
FREMONT, CA – (NewMediaWire) – August 3, 2023 – ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company specializing in therapeutic solutio… Read More
FREMONT, CA – (NewMediaWire) – August 07, 2023 – ABVC BioPharma, Inc. (NASDAQ: ABVC) (“Company”), a clinical-stage biopharmaceutical company… Read More
FREMONT, CA – (NewMediaWire) – August 17, 2023 – ABVC BioPharma,
Inc. (NASDAQ: ABVC) (“Company”), a
clinical-stage biopharmaceutical company develop… Read More
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Attention Deficit Hyperactivity Disorder pipeline constitutes 20+ key companies continuously working to… Read More
FREMONT, CA – (NewMediaWire) – October 17, 2023 – ABVC BioPharma, Inc. (NASDAQ: ABVC) (“Company”), a clinical-stage biopharmaceutical company dev… Read More
FREMONT, CA – (NewMediaWire) – October 26, 2023 – ABVC BioPharma, Inc. (NASDAQ: ABVC) (“Company”), a clinical-stage biopharmaceutical compan… Read More
FREMONT, CA – (NewMediaWire) – November 15, 2023 – ABVC BioPharma, Inc. (NASDAQ: ABVC) (“Company”): Today, a biotechnology company specializ… Read More
FREMONT, CA – (NewMediaWire) – November 16, 2023 – ABVC BioPharma, Inc. (NASDAQ: ABVC) (“Company”), a clinical-stage biopharmaceutical compa… Read More
FREMONT, CA – (NewMediaWire) – November 21, 2023 – ABVC BioPharma, Inc. (NASDAQ: ABVC) (“Company”), a clinical-stage biopharmaceutical company developi… Read More
FREMONT, CA – (NewMediaWire) – December 07, 2023 – ABVC BioPharma, Inc. (NASDAQ: ABVC) (“Company”), a clinical-stage biopharmaceutical company develop… Read More
Right here’s at this time’s largest movers and shakers!
And a SPECIAL INVITE to affix Jeff Bishop @2pm EST TODAY as he shares his prime promoting choic… Read More
FREMONT, CA – (NewMediaWire) – January 3, 2024 – ABVC BioPharma, Inc. (NASDAQ: ABVC) and its subsidiary BioLite, Inc. (“Company”), a clinica… Read More
FREMONT, CA – (NewMediaWire) – February 8, 2024 – ABVC BioPharma, Inc. (NASDAQ: ABVC) (“Company”), a clinical-stage biopharmaceutical company developin… Read More
FREMONT, CA – (NewMediaWire) – February 15, 2024 – ABVC BioPharma, Inc. (NASDAQ: ABVC) (“Company”), a clinical-stage biopharmaceutical company dev… Read More